Veterinary Medicine and Science,
Journal Year:
2024,
Volume and Issue:
10(2)
Published: Feb. 28, 2024
Abstract
Background
Effect
of
antibacterials
on
mucociliary
system
and
clinical
outcome
chickens
with
mixed
viral
respiratory
conditions
is
not
properly
addressed.
Objective
We
evaluated
enrofloxacin
effects
parameters
broilers
challenged
H9N2/IB
viruses.
Methods
Broilers
(105),
at
the
age
25
days,
were
randomly
allocated
into
three
groups:
Group
1
(negative
control),
no
treatment;
2
(positive
control
[PC])
by
intranasal
intraocular
route.
3
(antibiotic
[AB]‐treated)
also
received
started
after
manifestation
signs
(day
post‐challenge
[pc])
continued
for
5
days.
Results
Administration
AB
was
associated
appreciable
changes
in
body
weight,
feed
conversion
ratio
(FCR)
or
severity
although
it
slightly
reduced
mortality
rate
as
compared
to
PC
group
(
p
>
0.05).
Virus
shedding
period
number
virus
positive
tracheal
caecal
tonsil
samples
statistically
similar
between
groups.
In
necropsy,
most
profound
effect
decreased
pleuropneumonia
score
day
12
pc.
Histopathological
lesion
scores
same
However,
administration
increased
goblet
cells,
ciliostasis.
Conclusions
found
a
weak
H9N2/IB‐infected
chickens.
Considering
risks
treatment
broiler
chickens,
results
this
small‐scale
study
do
encourage
benefit
use
these
diseases.
Frontiers in Veterinary Science,
Journal Year:
2024,
Volume and Issue:
11
Published: Sept. 9, 2024
The
poultry
industry,
a
cornerstone
of
global
food
security,
faces
dynamic
challenges
exacerbated
by
viral
diseases.
This
review
traces
the
trajectory
vaccination,
evolving
from
traditional
methods
to
forefront
innovation
Virus-Like
Particle
(VLP)
vaccines.
Vaccination
has
been
pivotal
in
disease
control,
but
vaccines
exhibit
some
limitations.
examines
emergence
VLPs
as
game-changer
vaccination.
VLPs,
mimicking
viruses
without
replication,
offer
safer,
targeted
alternative
with
enhanced
immunogenicity.
narrative
encompasses
VLP
design
principles,
production
methods,
immunogenicity,
and
efficacy
against
major
viruses.
Challenges
prospects
are
explored,
presenting
transformative
technique
control.
Understanding
their
potential
empowers
industry
stakeholders
navigate
health
management
precision,
promising
improved
welfare,
reduced
economic
losses,
heightened
safety.
Journal of Agronomy Technology and Engineering Management (JATEM),
Journal Year:
2023,
Volume and Issue:
6(6), P. 975 - 987
Published: Nov. 10, 2023
Colibacillosis,
a
bacterial
infection
caused
by
pathogenic
Escherichia
coli
strains,
poses
significant
challenges
to
contemporary
poultry
farming.
This
paper
provides
succinct
overview
of
key
aspects
related
the
disease.
Colibacillosis
manifests
with
respiratory,
enteric,
and
systemic
clinical
signs,
impacting
broilers,
layers,
breeders.
The
etiology
involves
virulent
E.
strains
specific
adhesion
invasion
mechanisms.
avian
immune
response
plays
crucial
role,
influenced
factors
such
as
age,
stress,
vaccination.
epidemiology
exhibits
global
prevalence,
geographical,
seasonal,
farm-specific
factors.
Control
strategies
encompass
biosecurity
measures,
vaccination,
responsible
antimicrobial
use,
genetic
selection,
environmental
management.
Comprehensive
understanding
proactive
management
colibacillosis
are
essential
mitigate
economic
losses
sustain
health
productivity
in
modern
production
systems.
In
conclusion
remains
challenge
production,
implications
for
industry.
Efforts
control
manage
should
take
into
consideration
these
multifaceted
focus
on
prevention,
early
detection,
use.
Poultry Science,
Journal Year:
2023,
Volume and Issue:
103(1), P. 103194 - 103194
Published: Oct. 14, 2023
Avian
influenza
(AI)
viruses
pose
a
risk
to
the
worldwide
poultry
industry.
Ultimately,
improving
efficiency
of
H9N2
vaccine
is
necessary
better
control
low-pathogenic
avian
influenza-H9N2
by
using
natural
immunostimulant.
Therefore,
goal
present
study
was
examine
varying
doses
cyanobacterium
Spirulina
extract
on
effectiveness
vaccine.
Thus,
total
150
specific
pathogen-free
(SPF)
chickens
were
allocated
into
6
groups,
25
birds
each,
as
follow:
G1,
G2,
and
G6
supplemented
with
200,
400,
400
mg
extract/kg
feed,
respectively,
whilst
feed
in
G3,
G4,
G5
not
extract.
At
21-days-old,
only
G3
vaccinated
AI
After
4
wk
postvaccination,
challenged
Egyptian
strain.
The
virus
selected
from
recent
circulating
strain
during
2022,
it
related
A/quail/Hong
Kong/G1/97-like
lineage
clustered
G1-B
sub-lineage
EGY-2
group.
It
had
high
amino
acids
identity
percentage
92.6%
A/chicken/Iran/av1221/1998
(Boehringer
Ingelheim)
results
real-time
reverse-transcriptase
polymerase-chain-reaction
(rRT-PCR)
revealed
that
no
shedding
reported
G5.
supplementation
low
(200
mg/kg
feed)
(400
concentration
(G1
G2)
induced
prominent
immuno-stimulatory
effect
dose
dependent
manner
where
strongly
enhanced
phagocytic
activities
broilers'
peripheral
blood
monocytes,
lysozyme
at
all
days
postvaccination
(dpv)
postchallenge
(dpc)
compared
other
groups
significant
differences
day
experiment
21st
dpv,
28th
7th
dpc,
14th
respectively.
G1
G2
highest
hemagglutination
inhibition
antibody
titer
dose-dependent
all-time
intervals.
significantly
increased
14th,
comparison
G3.
Furthermore,
showed
higher
titers
groups.
anti-inflammatory
dependant
downregulating
nitric
oxide
levels
times
difference
3
7
dpc
G6,
improved
histopathological
alterations
trachea,
lung,
kidney,
spleen,
bursa
Fabricius.
supplied
without
vaccination
similar
innate
immunity.
However,
delayed
production
antibodies
did
prevent
viral
In
conclusion,
conjunction
either
(G1,
prevents
shedding,
increases
immune
response,
reduces
inflammation
change
caused
infection
manner.
We
recommend
use
immunostimulant
achieve
possible
level
protection
against
infection.
Research Square (Research Square),
Journal Year:
2024,
Volume and Issue:
unknown
Published: Jan. 24, 2024
Abstract
This
study
explores
the
co-infection
dynamics
of
Pasteurella
multocida
(
P.multocida
)
in
poultry,
focusing
on
Avian
Leukosis
Virus
(ALV),
Mycoplasma
gallisepticum
(MG),
and
Chicken
Anemia
(CAV).
Co-infections
pose
significant
challenges
to
poultry
health,
leading
increased
morbidity
mortality
rates.
The
combined
impact
exacerbates
respiratory
issues,
weakens
immune
system,
leads
intricate
clinical
manifestations.
Samples
from
flocks
Telangana
Haryana
states
India,
suspected
for
fowl
cholera,
were
collected
during
2019–2021.
confirms
co-infections
using
conventional
PCR
techniques
targeting
specific
gene
regions.
Clinical
symptoms
exhibited
by
infected
birds
are
described
each
pathogen.
epidemiology
is
discussed,
importance
understanding
these
effective
control
prevention
strategies
emphasized.
Results
reveal
consistent
over
period,
highlighting
need
further
investigations
into
associations
with
parasites,
bacteria,
fungi,
or
viruses.
underscores
comprehensive
biosecurity
measures,
vaccination
programs,
early
detection
managing
ensuring
sustainable
production.
Veterinary Medicine and Science,
Journal Year:
2024,
Volume and Issue:
10(2)
Published: Feb. 28, 2024
Abstract
Background
Effect
of
antibacterials
on
mucociliary
system
and
clinical
outcome
chickens
with
mixed
viral
respiratory
conditions
is
not
properly
addressed.
Objective
We
evaluated
enrofloxacin
effects
parameters
broilers
challenged
H9N2/IB
viruses.
Methods
Broilers
(105),
at
the
age
25
days,
were
randomly
allocated
into
three
groups:
Group
1
(negative
control),
no
treatment;
2
(positive
control
[PC])
by
intranasal
intraocular
route.
3
(antibiotic
[AB]‐treated)
also
received
started
after
manifestation
signs
(day
post‐challenge
[pc])
continued
for
5
days.
Results
Administration
AB
was
associated
appreciable
changes
in
body
weight,
feed
conversion
ratio
(FCR)
or
severity
although
it
slightly
reduced
mortality
rate
as
compared
to
PC
group
(
p
>
0.05).
Virus
shedding
period
number
virus
positive
tracheal
caecal
tonsil
samples
statistically
similar
between
groups.
In
necropsy,
most
profound
effect
decreased
pleuropneumonia
score
day
12
pc.
Histopathological
lesion
scores
same
However,
administration
increased
goblet
cells,
ciliostasis.
Conclusions
found
a
weak
H9N2/IB‐infected
chickens.
Considering
risks
treatment
broiler
chickens,
results
this
small‐scale
study
do
encourage
benefit
use
these
diseases.